TITLE

Cohort Profile: The Danish HIV Cohort Study

AUTHOR(S)
Obel, Niels; Engsig, Frederik N.; Rasmussen, Line D.; Larsen, Mette V.; Omland, Lars H.; Sørensen, Henrik T.
PUB. DATE
October 2009
SOURCE
International Journal of Epidemiology;Oct2009, Vol. 38 Issue 5, p1202
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article features the Danish HIV Cohort Study (DHCS) which was initiated in 1998 as a collaborative effort by eight HIV treatment centres in Denmark. Niels Obel and the steering committee of the DHCS set up the cohort to estimate the number of HIV infected patients under treatment in the country and to monitor the effects of highly active antiretroviral therapy (HAART). The coverage of the cohort, the original research topics, the sample included in the DHCS, and the strengths and weaknesses of DHCS are also discussed.
ACCESSION #
45230192

 

Related Articles

  • Impact of Non-HIV and HIV Risk Factors on Survival in HIV-Infected Patients on HAART: A Population-Based Nationwide Cohort Study. Obel, Niels; Omland, Lars Haukali; Kronborg, Gitte; Larsen, Carsten S.; Pedersen, Court; Pedersen, Gitte; Sørensen, Henrik Toft; Gerstoft, Jan // PLoS ONE;2011, Vol. 6 Issue 7, p1 

    Background: We determined the impact of three factors on mortality in HIV-infected patients who had been on highly active antiretroviral therapy (HAART) for at least one year: (1) insufficient response to (HAART) and presence of AIDSdefining diseases, (2) comorbidity, and (3) drug and alcohol...

  • HIV treatment prevents transmission of HIV.  // Africa Health;May2011, Vol. 33 Issue 4, p11 

    The article discusses the report from the US National Institutes of Health which found that an effective antiretroviral therapy regimen for HIV-positive person could prevent the risk of transmitting the virus to their uninfected sexual partner.

  • Detection of immunological treatment failure among HIV infected patients in Ethiopia: a retrospective cohort study. Teshome, Wondu; Tefera, Ambachew // BMC Immunology;9/17/2015, Vol. 16 Issue 1, p1 

    Background: Timely detection of treatment failure with subsequent switch to second-line regimen reduces mortality among HIV infected people on antiretroviral therapy (ART). This paper aims to investigate the detection of immunological treatment failure and switch rate to second line regimen in...

  • Real Life HAART Efficacy in Chronically HIV-1 Infected Children 15-Year Follow-Up. Monpoux, Fabrice; Rubio, Amandine; Sakarovitch, Charlotte; Fontas, Eric; Cottalorda-Dufayard, Jacqueline; Pradier, Christian // Journal of AIDS & Clinical Research;2012, Vol. 3 Issue 8, Special section p1 

    Background: It is now widely accepted that the antiretroviral first line-treatment basis in HIV-1 infected children is a combination of 2 nucleoside reverse transcriptase inhibitors and 1 protease inhibitor or 1 non NRTI. However, after few months or years, some patients presented with...

  • A Measurement Model of Medication Adherence to Highly Active Antiretroviral Therapy and Its Relation to Viral Load in HIV-Positive Adults. Llabre, Maria M.; Weaver, Kathryn E.; Durán, Ron E.; Antoni, Michael H.; McPherson-Baker, Shvawn; Schneiderman, Neil // AIDS Patient Care & STDs;Oct2006, Vol. 20 Issue 10, p701 

    This study compared a multiple method measurement model of highly active antiretroviral therapy (HAART) adherence with single-method models to determine optimal validity in predicting HIV viral load. Repeated measures of antiretroviral adherence were collected over a 15-month period using three...

  • Effect of Free Treatment and Surveillance on HIV-Infected Persons Who Have Tuberculosis, Taiwan, 1993-2006. Shu-Hui Tseng; Dah-Shyong Jiang, Donald; Hao-Seong Hoi; Hsiu-Yun Lo; Kao-Pin Hwang // Emerging Infectious Diseases;Feb2009, Vol. 15 Issue 2, p332 

    In 1997, Taiwan made highly active antiretroviral therapy (HAART) available without cost to HIV-infected persons; in 2001, a national web-based surveillance system was implemented. Healthcare workers use the system to monitor patients' conditions and can intervene when necessary. Free HAART,...

  • Human Immunodeficiency Virus--Associated Lipoatrophy: Letting the Genome Out of the Bottle. Lichtenstein, Kenneth A. // Journal of Infectious Diseases;3/15/2008, Vol. 197 Issue 6, p784 

    The author reflects on the benefits of antiretrovial therapy in treating human immunodeficiency virus (HIV) infection. He discusses the potential role of genetic polymorphisms in predisposing HIV-infected patients who receive highly active antiretroviral therapy (HAART). The author believes that...

  • Cohort Profile: Standardized Management of Antiretroviral Therapy Cohort (MASTER Cohort). Torti, Carlo; Raffetti, Elena; Donato, Francesco; Castelli, Francesco; Maggiolo, Franco; Angarano, Gioacchino; Mazzotta, Francesco; Gori, Andrea; Sighinolfi, Laura; Pan, Angelo; Cauda, Roberto; Scalzini, Alfredo; Quiros-Roldan, Eugenia; Nasta, Paola; Gregis, Giampietro; Benatti, Simone; Digiambenedetto, Simona; Ladisa, Nicoletta; Giralda, Mariarosaria; Saracino, Annalisa // International Journal of Epidemiology;Apr2017, Vol. 46 Issue 2, p1 

    No abstract available.

  • Cohort profile: the Chinese national free antiretroviral treatment cohort. Ye Ma; Fujie Zhang; Yan Zhao; Chunpeng Zang; Decai Zhao; Zhihui Dou; Lan Yu; Hua Fang; Zhu, Timothy Y.; Chen, Ray Y.; Ma, Ye; Zhang, Fujie; Zhao, Yan; Zang, Chunpeng; Zhao, Decai; Dou, Zhihui; Yu, Lan; Fang, Hua // International Journal of Epidemiology;Aug2010, Vol. 39 Issue 4, p973 

    The article discusses the free antiretroviral therapy (ART) program in China which provides human immunodeficiency virus (HIV) treatment and care to rural and low-income urban patients who meet the guidelines. According to an observational cohort in 2004, the ART for adults is studied based on...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics